Trega Biosciences (TRGA), formerly HPIP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trega Biosciences (TRGA), formerly HPIP

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: E.J. Neitz Jr who wrote ()	2/24/2000 12:31:00 PM
From: bob zagorin	Read Replies (1) of 152

some edited comments from latest issue of Cal. Tech Stock Letter. "...Trega Biosciences...reported a 24%climb in revenue for 1999.The figure jumped from $10.8 million in 1998 to $13.4 million,due primarily to sales of their libraries of chemical compounds.Yearly net losses de- creased 32%from $12.7 million (89 cents per share)in 1998 to $8.7 million (47 cents a share)in 1999.Fourth quarter revenues showed a similar pattern,increasing 29% over the same period last year from $3.6 million to $4.6 million.The net loss for the December quarter was approximately 1 ½per share,a 95% decrease from the 21 ½net loss for the quarter last year.... ...TRGA attributes its financial improvement to the focus on selling chemical libraries and the technology of predict- ing and selecting drug candidates.Consistent with this strategy,this week they announced that they will not con- duct in-house drug discovery unless it is funded by a collaborator.They are turning themselves into a bioinformatics company,and Wall Street obviously likes the change....."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next